Pharmacoeconomic analysis of Xeomine® for treatment patients with focal dystonia
Focal dystonia is a large group of diverse neurological syndromes characterized by significant muscular contractions, spasms, repetitive movements, and persistent pathological poses (which in turn often causes pain syndrome). Blepharospasm (BSP) and cervical dystonia (CD) are two focal dystonias tha...
Main Authors: | S. K. Zyryanov, D. Yu. Belousov, A. E. Cheberda |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Izdatelstvo OKI
2018-05-01
|
Series: | Качественная клиническая практика |
Subjects: | |
Online Access: | https://www.clinvest.ru/jour/article/view/42 |
Similar Items
-
Pharmacoeconomic analysis of naftidrofuryl for treatment of ischemic stroke
by: A. E. Cheberda, et al.
Published: (2018-05-01) -
Фармакоэкономический анализ применения бортезомиба для подкожного введения у пациентов с рецидивирующей множественной миеломой
Published: (2018-06-01) -
Comparative pharmacoeconomic analysis of Paclical® and Taxol® in Russian Federation
by: A. E. Cheberda, et al.
Published: (2018-05-01) -
Pharmacoeconomic analysis of Cocarnit® complex as treatment for diabetic polyneuropathy
by: D. Yu. Belousov, et al.
Published: (2018-05-01) -
Pharmacoeconomic analysis of Actemra<sup>®</sup> in first-line treatment of rheumatoid arthritis in the modes of combination and monotherapy
by: S. K. Zyryanov, et al.
Published: (2018-05-01)